基因编辑在多能干细胞中的进展和前景
Zhenwu Zhang1, Xinyu Bao1, Chao-Po Lin1
1School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Biomedicines
|August 26, 2023
概括
人类多能干细胞 (PSC) 中的基因编辑需要谨慎,因为非目标突变和DNA损伤敏感性. 较新的双链断裂独立工具为基因疗法应用提供了更安全的替代方案.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 干细胞生物学 干细胞生物学
背景情况:
- 人类多能干细胞 (PSC) 中的基因编辑对于细胞疗法至关重要,但面临着挑战.
- 在PSC中非目标突变可以在后代中被放大.
- PSCs的DNA损伤敏感性可以降低编辑效率并损害基因组完整性.
研究的目的:
- 审查可编程核酶在PSC中用于基因编辑的当前应用.
- 讨论现有的基因编辑系统的优化策略.
- 探索用于差异化建模和治疗用途的新型基因编辑工具.
主要方法:
- 关于PSC基因编辑中的可编程核酶的当前文献的综述.
- 分析优化基因编辑效率和安全性的策略.
- 评估新兴的基因编辑技术,如基础编辑器,主要编辑器和Cas相关系统.
主要成果:
- 可编程核酶在PSC研究中被广泛使用,但具有非目标编辑和DNA损伤的风险.
- 双链断裂独立的基因编辑工具 (基础和主要编辑器) 可减轻这些风险.
- 像Cas相关核酶,转位子和重组酶这样的新系统扩大了基因编辑能力.
结论:
- 对基因编辑工具的仔细考虑对于PSC在细胞治疗中的应用至关重要.
- 独立于DSB的编辑器为PSC基因编辑提供了更好的安全配置文件.
- 新兴的基因编辑技术对推进差异化建模和治疗策略充满希望.
相关概念视频
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
Embryonic Stem Cells
28.8K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
28.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K


